Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells

Friedenstein, 1970, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell Tissue Kinet, 3, 393 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Hoogduijn, 2014, Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics?, Curr Opin Organ Transplant, 19, 41, 10.1097/MOT.0000000000000036 Lv, 2014, Concise review: the surface markers and identity of human mesenchymal stem cells, Stem Cells, 32, 1408, 10.1002/stem.1681 Phinney, 2013, Mesenchymal stromal cells: misconceptions and evolving concepts, Cytotherapy, 15, 140, 10.1016/j.jcyt.2012.11.005 Horwitz, 2005, Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234 Caplan, 2015, The MSC curtain that stops the immune system, Immunol Lett, 168, 136, 10.1016/j.imlet.2015.06.005 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Kolf, 2007, Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation, Arthritis Res Ther, 9, 204, 10.1186/ar2116 Bluestone, 2012, Current and future immunomodulation strategies to restore tolerance in autoimmune diseases, Cold Spring Harb Perspect Biol, 4, 10.1101/cshperspect.a007542 Li, 2011, Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche, Bone Marrow Res, 2011, 353878, 10.1155/2011/353878 Hoogduijn, 2015, Are mesenchymal stromal cells immune cells?, Arthritis Res Ther, 17, 88, 10.1186/s13075-015-0596-3 Krampera, 2013, Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal, Cytotherapy, 15, 1054, 10.1016/j.jcyt.2013.02.010 Bloom, 2015, A reproducible immunopotency assay to measure mesenchymal stromal cell–mediated T-cell suppression, Cytotherapy, 17, 140, 10.1016/j.jcyt.2014.10.002 Parekkadan, 2010, Mesenchymal stem cells as therapeutics, Annu Rev Biomed Eng, 12, 87, 10.1146/annurev-bioeng-070909-105309 Wang, 2012, Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration, J Dent Res, 91, 1003, 10.1177/0022034512460404 Majumdar, 2003, Characterization and functionality of cell surface molecules on human mesenchymal stem cells, J Biomed Sci, 10, 228, 10.1007/BF02256058 Najar, 2010, Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions, Exp Hematol, 38, 922, 10.1016/j.exphem.2010.05.007 Wang, 2014, Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications, Nat Immunol, 15, 1009, 10.1038/ni.3002 Charron, 2013, Allogenicity & immunogenicity in regenerative stem cell therapy, Indian J Med Res, 138, 749 Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x Consentius, 2015, Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?, Regen Med, 10, 305, 10.2217/rme.15.14 Najar, 2012, Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming, Stem Cell Rev, 8, 1188, 10.1007/s12015-012-9408-1 Ryan, 2005, Mesenchymal stem cells avoid allogeneic rejection, J Inflamm (Lond), 2, 8, 10.1186/1476-9255-2-8 Wuchter, 2015, Standardization of Good Manufacturing Practice–compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications, Cytotherapy, 17, 128, 10.1016/j.jcyt.2014.04.002 Menard, 2013, Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls, Stem Cells Dev, 22, 1789, 10.1089/scd.2012.0594 Nold, 2015, Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation, Cytotherapy, 17, 152, 10.1016/j.jcyt.2014.10.004 Jin, 2014, Substance P enhances mesenchymal stem cells-mediated immune modulation, Cytokine, 71, 145, 10.1016/j.cyto.2014.10.003 Moll, 2014, Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?, PLoS ONE, 9, e85040, 10.1371/journal.pone.0085040 Figueroa, 2012, Mesenchymal stem cell treatment for autoimmune diseases: a critical review, Biol Res, 45, 269, 10.4067/S0716-97602012000300008 English, 2013, Mechanisms of mesenchymal stromal cell immunomodulation, Immunol Cell Biol, 91, 19, 10.1038/icb.2012.56 Lippolis, 2008, Immunological signaling networks: integrating the body's immune response, J Anim Sci, 86, E53, 10.2527/jas.2007-0620 Soleymaninejadian, 2012, Immunomodulatory properties of mesenchymal stem cells: cytokines and factors, Am J Reprod Immunol, 67, 1, 10.1111/j.1600-0897.2011.01069.x Ma, 2014, Immunobiology of mesenchymal stem cells, Cell Death Differ, 21, 216, 10.1038/cdd.2013.158 Duffy, 2011, Mesenchymal stem cell effects on T-cell effector pathways, Stem Cell Res Ther, 2, 34, 10.1186/scrt75 Franquesa, 2012, Immunomodulatory effect of mesenchymal stem cells on B cells, Front Immunol, 3, 212, 10.3389/fimmu.2012.00212 Ribeiro, 2013, Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells, Stem Cell Res Ther, 4, 125, 10.1186/scrt336 Spaggiari, 2013, Interactions between mesenchymal stem cells and dendritic cells, Adv Biochem Eng Biotechnol, 130, 199 Laranjeira, 2015, Human bone marrow-derived mesenchymal stromal cells differentially inhibit cytokine production by peripheral blood monocytes subpopulations and myeloid dendritic cells, Stem Cells Int, 2015, 819084, 10.1155/2015/819084 Aldinucci, 2010, Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation, J Immunol, 185, 5102, 10.4049/jimmunol.1001332 Harizi, 2006, Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators, Cell Mol Immunol, 3, 271 Najar, 2015, Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10/CD210 axis, Stem Cell Rev, 11, 442, 10.1007/s12015-014-9567-3 Beyth, 2005, Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness, Blood, 105, 2214, 10.1182/blood-2004-07-2921 Zhao, 2012, Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells, Immunol Invest, 41, 183, 10.3109/08820139.2011.607877 Gur-Wahnon, 2007, Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling, Exp Hematol, 35, 426, 10.1016/j.exphem.2006.11.001 Li, 2008, Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway, J Immunol, 180, 1598, 10.4049/jimmunol.180.3.1598 Deng, 2014, Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1, Stem Cells Dev, 23, 2080, 10.1089/scd.2013.0559 Spaggiari, 2009, MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2, Blood, 113, 6576, 10.1182/blood-2009-02-203943 Wehner, 2009, Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells, Haematologica, 94, 1151, 10.3324/haematol.2008.001735 Han, 2006, Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway, J Biol Chem, 281, 24831, 10.1074/jbc.M602201200 Rutz, 2008, Notch regulates IL-10 production by T helper 1 cells, Proc Natl Acad Sci U S A, 105, 3497, 10.1073/pnas.0712102105 Kassner, 2010, Cutting edge: plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis, J Immunol, 184, 550, 10.4049/jimmunol.0903152 Whyte, 2011, Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function, J Leukoc Biol, 90, 845, 10.1189/jlb.1110644 Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 Martinez, 2008, Macrophage activation and polarization, Front Biosci, 13, 453, 10.2741/2692 François, 2012, Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation, Mol Ther, 20, 187, 10.1038/mt.2011.189 Melief, 2013, Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules, Haematologica, 98, e121, 10.3324/haematol.2013.093864 Bouffi, 2010, IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis, PLoS ONE, 5, e14247, 10.1371/journal.pone.0014247 Williams, 2000, Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase, J Interferon Cytokine Res, 20, 291, 10.1089/107999000312423 Liu, 2006, Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system, Ann N Y Acad Sci, 1068, 225, 10.1196/annals.1346.047 Kozawa, 1998, Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein kinase C, Bone, 22, 355, 10.1016/S8756-3282(97)00293-7 Chen, 2014, Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2, J Leukoc Biol, 96, 295, 10.1189/jlb.3A0513-242R Ingulli, 2010, Mechanism of cellular rejection in transplantation, Pediatr Nephrol, 25, 61, 10.1007/s00467-008-1020-x Jiang, 2014, CD4(+)CD25 (+) regulatory T cells are not required for mesenchymal stem cell function in fully MHC-mismatched mouse cardiac transplantation, Cell Tissue Res, 358, 503, 10.1007/s00441-014-1956-z Di Ianni, 2008, Mesenchymal cells recruit and regulate T regulatory cells, Exp Hematol, 36, 309, 10.1016/j.exphem.2007.11.007 Castro-Manrreza, 2014, Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells, Stem Cells Dev, 23, 1217, 10.1089/scd.2013.0363 Prevosto, 2007, Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction, Haematologica, 92, 881, 10.3324/haematol.11240 Maccario, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516 Luz-Crawford, 2013, Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells, Stem Cell Res Ther, 4, 65, 10.1186/scrt216 Burr, 2013, Mesenchymal stromal cells and regulatory T cells: the yin and yang of peripheral tolerance?, Immunol Cell Biol, 91, 12, 10.1038/icb.2012.60 Batten, 2006, Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves, Tissue Eng, 12, 2263, 10.1089/ten.2006.12.2263 Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554 Nasef, 2008, Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression, Cell Immunol, 253, 16, 10.1016/j.cellimm.2008.06.002 English, 2009, Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells, Clin Exp Immunol, 156, 149, 10.1111/j.1365-2249.2009.03874.x Mougiakakos, 2011, The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells, Blood, 117, 4826, 10.1182/blood-2010-12-324038 Engela, 2013, Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA, Clin Exp Immunol, 173, 343, 10.1111/cei.12120 Dokić, 2013, Mesenchymal stem cells from periapical lesions modulate differentiation and functional properties of monocyte-derived dendritic cells, Eur J Immunol, 43, 1862, 10.1002/eji.201243010 Bukulmez, 2014, Immunomodulatory factors produced by mesenchymal stem cells after in vitro priming with danger signals, Arthritis Rheumatol, 66, S163, 10.1002/art.38546 Ghannam, 2010, Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype, J Immunol, 185, 302, 10.4049/jimmunol.0902007 Yang, 2015, Crosstalk between bone marrow-derived mesenchymal stem cells and regulatory T cells through a glucocorticoid-induced leucine zipper/developmental endothelial locus-1-dependent mechanism, FASEB J, 29, 3954, 10.1096/fj.15-273664 Calmette, 2014, Glucocorticoid-induced leucine zipper enhanced expression in dendritic cells is sufficient to drive regulatory T cells expansion in vivo, J Immunol, 193, 5863, 10.4049/jimmunol.1400758 Wang, 2009, CD8 regulatory T cells: what's old is now new, Immunol Cell Biol, 87, 192, 10.1038/icb.2009.8 Liu, 2014, Human mesenchymal stromal cells enhance the immunomodulatory function of CD8+CD28- regulatory T cells, Cell Mol Immunol, 12, 708, 10.1038/cmi.2014.118 Baratelli, 2010, PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer, Am J Transl Res, 2, 356 Horita, 2007, Induction of prostaglandin E2 production by leukemia inhibitory factor promotes migration of first trimester extravillous trophoblast cell line, HTR-8/SVneo, Hum Reprod, 22, 1801, 10.1093/humrep/dem125 Schluns, 1995, Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors, Int Immunol, 7, 1681, 10.1093/intimm/7.10.1681 Chen, 2014, Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression, Breast Cancer Res, 16, 410, 10.1186/s13058-014-0410-1 Chen, 2011, IDO: more than an enzyme, Nat Immunol, 12, 809, 10.1038/ni.2088 Belladonna, 2009, TGF-beta and kynurenines as the key to infectious tolerance, Trends Mol Med, 15, 41, 10.1016/j.molmed.2008.11.006 Le Rond, 2005, Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways, Immunology, 116, 297, 10.1111/j.1365-2567.2005.02224.x López, 2006, Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells, Mol Immunol, 43, 2151, 10.1016/j.molimm.2006.01.007 McIntire, 2004, Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1, J Leukoc Biol, 76, 1220, 10.1189/jlb.0604337 Gangi, 2005, IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis, J Immunol, 174, 7006, 10.4049/jimmunol.174.11.7006 Mittal, 2009, Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors, Transplantation, 88, 435, 10.1097/TP.0b013e3181af20fd Jonuleit, 2003, The regulatory T cell family: distinct subsets and their interrelations, J Immunol, 171, 6323, 10.4049/jimmunol.171.12.6323 Im, 2014, Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance, Stem Cells Dev, 23, 2364, 10.1089/scd.2013.0617 Zhou, 2014, Regulatory T cells enhance mesenchymal stem cell survival and proliferation following autologous cotransplantation in ischemic myocardium, J Thorac Cardiovasc Surg, 148, 1131, 10.1016/j.jtcvs.2014.06.029 Quinn, 2014, The role of microRNAs in the control and mechanism of action of IL-10, Curr Top Microbiol Immunol, 380, 145 Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657 Mauri, 2012, Immune regulatory function of B cells, Annu Rev Immunol, 30, 221, 10.1146/annurev-immunol-020711-074934 Bouaziz, 2008, Regulatory B cells as inhibitors of immune responses and inflammation, Immunol Rev, 224, 201, 10.1111/j.1600-065X.2008.00661.x Yang, 2013, Regulatory B cells in autoimmune diseases, Cell Mol Immunol, 10, 122, 10.1038/cmi.2012.60 Rosser, 2014, Cellular targets of regulatory B cell-mediated suppression, Mol Immunol, 62, 296, 10.1016/j.molimm.2014.01.014 Vadasz, 2013, B-regulatory cells in autoimmunity and immune mediated inflammation, FEBS Lett, 587, 2074, 10.1016/j.febslet.2013.05.023 Mauri, 2014, Interleukin-35 takes the “B” line, Nat Med, 20, 580, 10.1038/nm.3594 Guo, 2013, Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis, Neuroimmunomodulation, 20, 294, 10.1159/000351450 Franquesa, 2015, Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells, Stem Cells, 33, 880, 10.1002/stem.1881 Park, 2015, Adipose tissue-derived mesenchymal stem cells induce expansion of Interleukin-10 producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus, Cell Transplant, 24, 2367, 10.3727/096368914X685645 Peng, 2015, Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10, Leukemia, 29, 636, 10.1038/leu.2014.225 Reinders, 2014, NK Cells and MSCs: possible implications for MSC therapy in renal transplantation, J Stem Cell Res Ther, 4, 1000166, 10.4172/2157-7633.1000166 Sotiropoulou, 2006, Interactions between human mesenchymal stem cells and natural killer cells, Stem Cells, 24, 74, 10.1634/stemcells.2004-0359 Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775 Spaggiari, 2008, Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2, Blood, 111, 1327, 10.1182/blood-2007-02-074997 Casado, 2013, NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity, Stem Cell Rev, 9, 184, 10.1007/s12015-013-9430-y Chatterjee, 2014, Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells, Blood, 123, 594, 10.1182/blood-2013-09-524827 Hoogduijn, 2011, Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies, Hum Gene Ther, 22, 1587, 10.1089/hum.2011.039 Götherström, 2011, Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways, Cytotherapy, 13, 269, 10.3109/14653249.2010.523077 Jewett, 2010, Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity, PLoS ONE, 5, e9874, 10.1371/journal.pone.0009874 Poggi, 2005, Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors, J Immunol, 175, 6352, 10.4049/jimmunol.175.10.6352 Noone, 2013, IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro, Stem Cells Dev, 22, 3003, 10.1089/scd.2013.0028 Giuliani, 2014, TLR ligands stimulation protects MSC from NK killing, Stem Cells, 32, 290, 10.1002/stem.1563 Matsuda, 2008, CD1d-restricted iNKT cells, the “Swiss-Army knife” of the immune system, Curr Opin Immunol, 20, 358, 10.1016/j.coi.2008.03.018 Taniguchi, 2010, The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy, Int Immunol, 22, 1, 10.1093/intimm/dxp104 Prigione, 2009, Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells, Stem Cells, 27, 693, 10.1634/stemcells.2008-0687 Fu, 2014, Subsets of human natural killer cells and their regulatory effects, Immunology, 141, 483, 10.1111/imm.12224